PYC THERAPEUTICS LIMITED — Director's Dealing 2014

Dec 23, 2014

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	RICHARD MILES HOPKINS
Date of last notice	8th January 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest	(1) RICHARD MILES HOPKINS & MAYA ANNE
(including registered holder)	MAUREEN VANDEN DRIESEN <VANHOP
Note: Provide details of the circumstances giving riseto the relevant interest.	SUPERANNUATION FUND >
	Trustee & Beneficiary of fund
	(2) MAYA VANDEN DRIESEN
	Wife
	(3) VANHOP PTY LTD
	Director of Trustee & Beneficiary of fund
**Date of change **	24THDECEMBER 2014
No. of securities held prior to change	DIRECT:
	- 7,710,121 ORDINARY SHARES
	- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/14
	- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/15
	- 2,040,000 ORDINARY SHARES RESTRICTED 03/06/16
	- 211,864 PYCOA OPTIONS EXERCISABLE AT $0.09
	EXPIRING 30/06/16
	INDIRECT:
	(1) RICHARD MILES HOPKINS & MAYA ANNE
	MAUREEN VANDEN DRIESEN <VANHOP
	SUPERANNUATION FUND >
	- 730,994 ORDINARY SHARES
	- 292,398 PYCOA OPTIONS EXERCISABLE AT
	$0.09 EXPIRING 30/06/16

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	(2) MAYA VANDEN DRIESEN
	- 274,924 ORDINARY SHARES
	(3) VANHOP PTY LTD
	- 1,771,572 ORDINARY SHARES
Class	UNLISTED OPTIONS
Number acquired	INDIRECT
	(3) 6,500,000
Nature of change	ALLOTMENT PURSUANT TO SHAREHOLDER
Example: on‐market trade, off‐market trade, exerciseof options, issue of securities under dividend	APPROVAL RECEIVED 27THNOVEMBER 2014.
reinvestmentplan, participation in buy‐back
Number disposed	NIL
Value/Consideration	ISSUED FREE
Note: If consideration is non‐cash, provide details and
estimated valuation
No. of securities held after change	DIRECT:
	- 7,710,121 ORDINARY SHARES
	- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/14
	- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/15
	- 2,040,000 ORDINARY SHARES RESTRICTED 03/06/16
	- 211,864 PYCOA OPTIONS EXERCISABLE AT $0.09
	EXPIRING 30/06/16
	INDIRECT:
	(1) RICHARD MILES HOPKINS & MAYA ANNE
	MAUREEN VANDEN DRIESEN <VANHOP
	SUPERANNUATION FUND >
	- 730,994 ORDINARY SHARES
	- 292,398 PYCOA OPTIONS EXERCISABLE AT
	$0.09 EXPIRING 30/06/16
	(2) MAYA VANDEN DRIESEN
	- 274,924 ORDINARY SHARES
	(3) VANHOP PTY LTD
	- 1,771,572 ORDINARY SHARES
	- 6,500,000 UNLISTED OPTIONS EXERCISABLE
	AT $0.025 EXPIRING 23/09/2017

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during thisperiod?	N/A
Ifprior written clearance wasprovided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3